Clinical Trials

Phase 3 Active not recruiting

Breast Neoplasms

NCT05286684 2026-03-18

Exo-LCR

Phase NA Completed

7 enrolled

BreastCNS

Breast Neoplasms, Meningeal Carcinomatosis

NCT05654623 2026-03-18

VERITAC-2

624 enrolled 17 charts

Breast Neoplasms

NCT05743686 2026-03-18

App for Adverse Events to Oral Chemotherapy - Pilot Study

Phase NA Completed

28 enrolled

Breast Neoplasms

NCT05787834 2026-03-18

Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Breast Cancer

130 enrolled

Breast Neoplasms

NCT05941520 2026-03-18

Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer

Phase 2 Recruiting

80 enrolled

Phase 1 Not yet recruiting

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT06148038 2026-03-18

CBD for Breast Cancer Primary Tumors

60 enrolled

Breast Neoplasms

NCT06184750 2026-03-18

Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

Phase 2 Recruiting

200 enrolled

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT06324357 2026-03-18

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Phase 1/2 Recruiting

768 enrolled

BreastGastrointestinal

Adenocarcinoma Of Esophagus, Breast Neoplasms, Colorectal Neoplasms

NCT06377852 2026-03-18

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

Phase 3 Recruiting

500 enrolled

Breast Neoplasms

NCT06428799 2026-03-18

EMBLEDDA-MMG

Completed

122 enrolled

Phase 1/2 Active not recruiting

Breast Neoplasms

NCT06590857 2026-03-18

TRACY-1

16 enrolled

Breast Neoplasms

NCT06625775 2026-03-18

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

BreastGastrointestinalThoracic

392 enrolled

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

NCT06833853 2026-03-18

CTC-EXPRESS

Recruiting

187 enrolled

Phase 1 Not yet recruiting

Breast Neoplasms

NCT06982222 2026-03-18

Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones

24 enrolled

BreastGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Prostatic Neoplasms

NCT06995898 2026-03-18

The Vanguard Study: Testing a New Way to Screen for Cancer

BreastGastrointestinalGenitourinaryGynecologicThoracic

24,000 enrolled

Urinary Bladder Neoplasms, Breast Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT07015944 2026-03-18

Moving On ABC

26,376 enrolled

Breast Neoplasms, Depression, Depressive Disorder, Major

NCT07137416 2026-03-18

Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer

36 enrolled

Breast Neoplasms, Neoplasm Metastasis, Triple Negative Breast Neoplasms

NCT07205822 2026-03-18

TB06

Phase 3 Recruiting

100 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT07222267 2026-03-18

An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors

86 enrolled

BreastDermatologicGastrointestinalGenitourinaryOther hematologic neoplasm

Breast Neoplasms

NCT07328516 2026-03-18

Natural History Study of Early Life Exposures in Agriculture (ELEA)

Enrolling by invitation

64,277 enrolled

Breast Neoplasms, Leukemia, Melanoma, Prostatic Neoplasms, Colorectal Neoplasms

NCT07424547 2026-03-18

Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors

BreastGenitourinaryGynecologicThoracic

386 enrolled

Breast Neoplasms, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Small Cell Lung Carcinoma

NCT07446868 2026-03-18

SPSIP-ESPB

50 enrolled

Breast Neoplasms, Pain, Postoperative

NCT07478900 2026-03-18

TUMS

30 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT07478939 2026-03-18

GYMNOS Project

Completed

507 enrolled

Behavior, Breast Neoplasms, Motor Activity

NCT00893061 2026-03-17

MNEMOSYNE

Phase 3 Completed

44 enrolled

Breast Neoplasms

NCT02281149 2026-03-17

TOMOBREAST

Active not recruiting

500 enrolled

Phase 2 Active not recruiting

Breast Neoplasms

NCT02482376 2026-03-17

Preoperative Single-Fraction Radiotherapy in Early Stage Breast Cancer

110 enrolled 18 charts

Breast Neoplasms

NCT02553967 2026-03-17

REMASCO

Phase NA Completed

49 enrolled

Phase 3 Active not recruiting

Breast Neoplasms

NCT02954874 2026-03-17

Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

1,155 enrolled

BreastEndocrineGynecologicNETPlasma cellThoracic

Breast Carcinoma In Situ, Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03412877 2026-03-17

Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer

Phase 2 Recruiting

285 enrolled

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Multiple Myeloma, Ovarian Neoplasms, Urogenital Neoplasms, Neuroendocrine Tumors

NCT04119024 2026-03-17

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

BreastCNSDermatologicEndocrineHead & NeckNETThoracic

18 enrolled

Adenocarcinoma of Lung, Squamous Cell Carcinoma of Head and Neck, Uveal Melanoma, Breast Neoplasms, Adenoma, Islet Cell, Melanoma, Neoplasm Metastasis, Paraganglioma, Pheochromocytoma, Thyroid Neoplasms, Adrenocortical Carcinoma, Neuroendocrine Tumors

NCT04191499 2026-03-17

INAVO120

Phase 2/3 Active not recruiting

325 enrolled 14 charts 1 FDA

Phase NA Active not recruiting

Breast Neoplasms

NCT04653740 2026-03-17

OMERIC

25 enrolled